Status:
COMPLETED
Endometrial Advancement After Rec or u-HCG Triggering
Lead Sponsor:
Universitair Ziekenhuis Brussel
Collaborating Sponsors:
Merck Serono International SA
Conditions:
Infertility
Eligibility:
FEMALE
20-36 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate any potential advantages of replacing human chorionic gonadotropin (uhCG) with recombinant human chorionic gonadotropin (recHCG) for final oocyte maturation...
Detailed Description
Biopsies of endometrium were taken in different groups Pregnancy rates were compared among defferent groups
Eligibility Criteria
Inclusion
- Less than 36 years old
- Male or tubal infertility
- FSH\<12 on day 3
Exclusion
- Endometriosis stage 3 \& 4
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00953628
Start Date
August 1 2005
End Date
December 1 2008
Last Update
December 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Reproductive Medicine, UZ Brussel
Brussels, Jette, Belgium, 1090